| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | +12.0% |
| Cost of Revenue | $1.1M | +40.8% |
| Gross Profit | $1.5M | -1.9% |
| R&D Expense | $909K | +391.4% |
| SG&A Expense | $3.5M | -11.8% |
| Operating Income | -$3.6M | -4.2% |
| Interest Expense | $135K | +0.0% |
| Pre-tax Income | -$3.7M | -0.1% |
| Income Tax | $19K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $98K | -69.2% |
| Inventory | $2.2M | -19.8% |
| Current Assets | $3.3M | -48.7% |
| Total Assets | $3.6M | -45.6% |
| Current Liabilities | $2.7M | +10.9% |
| Total Liabilities | $3.0M | +11.8% |
| Stockholders' Equity | $627K | -84.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.5M | +30.1% |
| Capital Expenditures | $3K | +200.0% |
| Investing Cash Flow | -$3K | -200.0% |
| Financing Cash Flow | $1K | -100.0% |
| Free Cash Flow | -$2.5M | +30.1% |
| -34.5% |
| Net Income | -$3.7M | +0.2% |
| EPS (Basic) | -$13.73 | -547.6% |
| EPS (Diluted) | -$13.73 | -547.6% |